Literature DB >> 9624595

Urinary cortisol metabolites in the assessment of peripheral thyroid hormone action: overt and subclinical hypothyroidism.

M C Vantyghem1, A Ghulam, C Hober, C Schoonberg, M D'Herbomez, A Racadot, A Boersma, J Lefebvre.   

Abstract

UNLABELLED: Biological assessment of peripheral thyroid hormone action may be important in subclinical hypothyroidism, where decision-making is often difficult. The impairment of urinary cortisol metabolites in overt hypothyroidism reflects an acquired 11 beta hydroxysteroid dehydrogenase (11 beta OHSD) deficiency, and is assessed in terms of a reduction in the tetrahydrocortisone (THE)/tetrahydrocortisol (THF) ratio or THE/THE + alpha THF ratio; the alpha THF/THF ratio reflects 5 beta reductase activity. The aim of this study was to determine if urinary cortisol metabolite ratios are a good index of peripheral thyroid hormone action in subclinical hypothyroidism.
MATERIALS AND METHODS: the THE/THF, THE/THF + alpha THF and alpha THF/THF ratios were measured in 24 h urine samples from 3 groups of subjects: 1) 18 euthyroid subjects; 2) 25 patients with elevated serum TSH and low FT4 levels (overt hypothyroidism); and 3) 25 patients with increased serum TSH and normal FT4 levels (subclinical hypothyroidism.
RESULTS: 7/25 overtly and 5/25 subclinically hypothyroid patients had a THE/THF + alpha THF ratio below the mean control value -2 SD, while respectively 20/25 and 11/25 patients had a THE/THF ratio below the mean control value -2 SD. The mean THE/THF + alpha THF, THE/THF and alpha THF/THF ratios were significantly different among the 3 groups (ANOVA) and were lower in the overtly hypothyroid group than in the other two groups (Fisher's test); daily urine sodium output was also significantly different between the three groups and lower in the overtly and subclinically hypothyroid groups than in the control group (Fisher's test). FT3 and FT4 both correlated with THE/THF + alpha THF in the overtly hypothyroid patients (r = 0.43; p < 0.05 and r = 0.40; p < 0.05, respectively). In the subclinically hypothyroid patients, TSH correlated with THE/THF + alpha THF (r = 0.44; p < 0.05) and THE/THF (r = 0.43; p < 0.05). FT3, FT4 and TSH levels correlated with THE/THF + alpha THF (p < 0.001), THE/THF (p < 0.001), alpha THF/THF (p < 0.001) and daily natriuresis (p < 0.05) in the whole population (patients + controls). In conclusion, urinary cortisol metabolites, although impaired in overt hypothyroidism, are not an accurate index of peripheral thyroid hormone deficiency in subclinical hypothyroidism. We also identified an increase in the alpha THF/THF ratio in overt hypothyroidism, which may be related to 5 beta reductase disturbances.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9624595     DOI: 10.1007/BF03347306

Source DB:  PubMed          Journal:  J Endocrinol Invest        ISSN: 0391-4097            Impact factor:   4.256


  28 in total

1.  The influence of thyroid hormone on hydrocortisone production and metabolism.

Authors:  L HELLMAN; H L BRADLOW; B ZUMOFF; T F GALLAGHER
Journal:  J Clin Endocrinol Metab       Date:  1961-10       Impact factor: 5.958

2.  [Production rate and mean plasma concentration of cortisol in hyperthyroidism (author's transl)].

Authors:  M Linquette; J Lefebvre; A Racadot; J P Cappoen; S Fontaine-Delort
Journal:  Ann Endocrinol (Paris)       Date:  1976 Sep-Oct       Impact factor: 2.478

3.  Effects of thyroid function on blood pressure. Recognition of hypothyroid hypertension.

Authors:  D H Streeten; G H Anderson; T Howland; R Chiang; H Smulyan
Journal:  Hypertension       Date:  1988-01       Impact factor: 10.190

4.  Spectrum of subclinical and overt hypothyroidism: effect on thyrotropin, prolactin, and thyroid reserve, and metabolic impact on peripheral target tissues.

Authors:  J J Staub; B U Althaus; H Engler; A S Ryff; P Trabucco; K Marquardt; D Burckhardt; J Girard; B D Weintraub
Journal:  Am J Med       Date:  1992-06       Impact factor: 4.965

5.  Thyroxine replacement therapy and circulating lipid concentrations.

Authors:  J A Franklyn; J Daykin; J Betteridge; E A Hughes; R Holder; S R Jones; M C Sheppard
Journal:  Clin Endocrinol (Oxf)       Date:  1993-05       Impact factor: 3.478

6.  Increased mean serum thyrotropin in apparently euthyroid hypercholesterolemic patients: does it mean occult hypothyroidism?

Authors:  D Pallas; D A Koutras; P Adamopoulos; P Marafelia; A Souvatzoglou; G Piperingos; S D Moulopoulos
Journal:  J Endocrinol Invest       Date:  1991-10       Impact factor: 4.256

7.  Urinary cortisol metabolites in the assessment of peripheral thyroid hormone action: application for diagnosis of resistance to thyroid hormone.

Authors:  M Taniyama; K Honma; Y Ban
Journal:  Thyroid       Date:  1993       Impact factor: 6.568

8.  Simultaneous estimation of urinary steroids by semi-automated gas chromatography. Investigation of neo-natal infants and children with abnormal steroid synthesis.

Authors:  C H Shackleton; J W Honour
Journal:  Clin Chim Acta       Date:  1976-06-01       Impact factor: 3.786

9.  The syndrome of apparent mineralocorticoid excess: its association with 11 beta-dehydrogenase and 5 beta-reductase deficiency and some consequences for corticosteroid metabolism.

Authors:  C Monder; C H Shackleton; H L Bradlow; M I New; E Stoner; F Iohan; V Lakshmi
Journal:  J Clin Endocrinol Metab       Date:  1986-09       Impact factor: 5.958

10.  Human hypertension caused by mutations in the kidney isozyme of 11 beta-hydroxysteroid dehydrogenase.

Authors:  T Mune; F M Rogerson; H Nikkilä; A K Agarwal; P C White
Journal:  Nat Genet       Date:  1995-08       Impact factor: 38.330

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.